Lauren M Abbate1, Amy S Jeffreys2, Cynthia J Coffman3, Todd A Schwartz4, Liubov Arbeeva5, Leigh F Callahan5, Nicole A Negbenebor6, Wendy M Kohrt1, Robert S Schwartz1, Ernest Vina7, Kelli D Allen8. 1. Veterans Affairs Eastern Colorado Healthcare System, Denver, and University of Colorado School of Medicine, Aurora. 2. Veterans Affairs Medical Center, Durham, North Carolina. 3. Veterans Affairs Medical Center and Duke University Medical Center, Durham, North Carolina. 4. Gillings School of Global Public Health, University of North Carolina, Chapel Hill. 5. University of North Carolina, Chapel Hill. 6. Warren Alpert Medical School at Brown University, Providence, Rhode Island. 7. University of Arizona College of Medicine, Tucson. 8. Veterans Affairs Medical Center, Durham, and University of North Carolina, Chapel Hill.
Abstract
OBJECTIVE: To identify patient demographic and clinical characteristics associated with osteoarthritis (OA) treatment use. METHODS: This was a secondary data analysis of 3 clinical trials among patients with hip or knee OA conducted in Duke Primary Care practices, the Durham Veterans Affairs (VA) Health Care System, and the University of North Carolina-Chapel Hill (UNC). At baseline, participants reported sociodemographic characteristics, OA-related pain and function, and OA treatment use, including oral analgesics, topical creams, joint injections, and physical therapy. Separate, multivariable logistic models (adjusted for clustering of clinics and providers for the Duke and VA cohorts) were used to estimate odds ratios (ORs) and 95% confidence intervals (95% CIs) for the associations between participant characteristics and each type of OA treatment. RESULTS: Oral analgesic use was reported by 70-82% of participants across the 3 cohorts. Physical therapy, knee injections, and topical creams were used by 39-52%, 55-60%, and 25-39% of Duke, VA, and UNC participants, respectively. In multivariable models, worse pain, stiffness, and function, per 5-unit increase, were associated with greater odds of using any oral analgesic for the cohorts from Duke (OR 1.18 [95% CI 1.08-1.28]) and UNC (OR 1.14 [95% CI 1.05-1.24]), but not for the VA cohort (OR 1.04 [95% CI 0.95-1.14]). For all 3 cohorts, nonwhites had higher odds of using topical creams compared to whites. CONCLUSION: Results suggest potential underutilization of therapies other than oral analgesics. Patient characteristics may affect OA treatment use, and understanding the relationship between these factors and OA treatment preferences may improve adherence to OA treatment guidelines.
OBJECTIVE: To identify patient demographic and clinical characteristics associated with osteoarthritis (OA) treatment use. METHODS: This was a secondary data analysis of 3 clinical trials among patients with hip or knee OA conducted in Duke Primary Care practices, the Durham Veterans Affairs (VA) Health Care System, and the University of North Carolina-Chapel Hill (UNC). At baseline, participants reported sociodemographic characteristics, OA-related pain and function, and OA treatment use, including oral analgesics, topical creams, joint injections, and physical therapy. Separate, multivariable logistic models (adjusted for clustering of clinics and providers for the Duke and VA cohorts) were used to estimate odds ratios (ORs) and 95% confidence intervals (95% CIs) for the associations between participant characteristics and each type of OA treatment. RESULTS: Oral analgesic use was reported by 70-82% of participants across the 3 cohorts. Physical therapy, knee injections, and topical creams were used by 39-52%, 55-60%, and 25-39% of Duke, VA, and UNC participants, respectively. In multivariable models, worse pain, stiffness, and function, per 5-unit increase, were associated with greater odds of using any oral analgesic for the cohorts from Duke (OR 1.18 [95% CI 1.08-1.28]) and UNC (OR 1.14 [95% CI 1.05-1.24]), but not for the VA cohort (OR 1.04 [95% CI 0.95-1.14]). For all 3 cohorts, nonwhites had higher odds of using topical creams compared to whites. CONCLUSION: Results suggest potential underutilization of therapies other than oral analgesics. Patient characteristics may affect OA treatment use, and understanding the relationship between these factors and OA treatment preferences may improve adherence to OA treatment guidelines.
Authors: Neena S Abraham; Christine Hartman; Peter Richardson; Diana Castillo; Richard L Street; Aanand D Naik Journal: Circulation Date: 2013-09-11 Impact factor: 29.690
Authors: Marc C Hochberg; Roy D Altman; Karine Toupin April; Maria Benkhalti; Gordon Guyatt; Jessie McGowan; Tanveer Towheed; Vivian Welch; George Wells; Peter Tugwell Journal: Arthritis Care Res (Hoboken) Date: 2012-04 Impact factor: 4.794
Authors: Joanne M Jordan; Charles G Helmick; Jordan B Renner; Gheorghe Luta; Anca D Dragomir; Janice Woodard; Fang Fang; Todd A Schwartz; Lauren M Abbate; Leigh F Callahan; William D Kalsbeek; Marc C Hochberg Journal: J Rheumatol Date: 2007-01 Impact factor: 4.666
Authors: Mark J Edlund; Bradley C Martin; Andrea Devries; Ming-Yu Fan; Jennifer Brennan Braden; Mark D Sullivan Journal: Clin J Pain Date: 2010-01 Impact factor: 3.442
Authors: Leah L Zullig; Hayden B Bosworth; Amy S Jeffreys; Leonor Corsino; Cynthia J Coffman; Eugene Z Oddone; William S Yancy; Kelli D Allen Journal: Clin Rheumatol Date: 2014-06-12 Impact factor: 2.980
Authors: Philip G Conaghan; Mark Porcheret; Sarah R Kingsbury; Anne Gammon; Ashok Soni; Michael Hurley; Margaret P Rayman; Julie Barlow; Richard G Hull; Jo Cumming; Kate Llewelyn; Federico Moscogiuri; Jane Lyons; Fraser Birrell Journal: Clin Rheumatol Date: 2014-06-03 Impact factor: 2.980
Authors: E R Vina; L R M Hausmann; D S Obrosky; A Youk; S A Ibrahim; D K Weiner; R M Gallagher; C K Kwoh Journal: Osteoarthritis Cartilage Date: 2019-02-01 Impact factor: 6.576
Authors: Ernest R Vina; Philip H Tsoukas; Shahrzad Abdollahi; Nidhi Mody; Stephanie C Roth; Albert H Redford; C Kent Kwoh Journal: Ther Adv Musculoskelet Dis Date: 2022-06-30 Impact factor: 3.625
Authors: Ernest R Vina; Michael J Hannon; Hana S Masood; Leslie R M Hausmann; Said A Ibrahim; Jazmin Dagnino; Andrea Arellano; C Kent Kwoh Journal: Am J Med Date: 2019-12-17 Impact factor: 4.965
Authors: Kelli D Allen; Brandon Sheets; Dennis Bongiorni; Ashley Choate; Cynthia J Coffman; Helen Hoenig; Kim Huffman; Elizabeth P Mahanna; Eugene Z Oddone; Courtney Van Houtven; Virginia Wang; Sandra Woolson; Susan N Hastings Journal: BMC Musculoskelet Disord Date: 2020-02-03 Impact factor: 2.362